Literature DB >> 19465915

PKC maturation is promoted by nucleotide pocket occupation independently of intrinsic kinase activity.

Angus J M Cameron1, Cristina Escribano, Adrian T Saurin, Brenda Kostelecky, Peter J Parker.   

Abstract

The protein kinase C (PKC) Ser/Thr kinases account for approximately 2% of the human kinome and regulate diverse cellular behaviors. PKC catalytic activity requires priming phosphorylations at three conserved sites within the kinase domain. Here we demonstrate that priming of PKC is dependent on the conformation of the nucleotide binding pocket but not on its intrinsic kinase activity. Inactive ATP binding site mutants are unprimed, but they become phosphorylated upon occupancy of the ATP binding pocket with inhibitors of PKC. We have exploited this property to screen for PKC inhibitors in vivo. Further, we generated a distinct class of kinase-inactive mutants that maintain the integrity of the ATP binding pocket; such mutants are constitutively primed and functionally distinct from ATP binding site mutants. These data demonstrate that autophosphorylation is not required for PKC priming and show how ATP pocket occupation can enable a kinase to mature as well as function.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19465915     DOI: 10.1038/nsmb.1606

Source DB:  PubMed          Journal:  Nat Struct Mol Biol        ISSN: 1545-9985            Impact factor:   15.369


  38 in total

1.  Multisite dephosphorylation and desensitization of conventional protein kinase C isotypes.

Authors:  G Hansra; P Garcia-Paramio; C Prevostel; R D Whelan; F Bornancin; P J Parker
Journal:  Biochem J       Date:  1999-09-01       Impact factor: 3.857

2.  Phosphorylation of protein kinase C-alpha on serine 657 controls the accumulation of active enzyme and contributes to its phosphatase-resistant state.

Authors:  F Bornancin; P J Parker
Journal:  J Biol Chem       Date:  1997-02-07       Impact factor: 5.157

3.  A phosphoserine/threonine-binding pocket in AGC kinases and PDK1 mediates activation by hydrophobic motif phosphorylation.

Authors:  Morten Frödin; Torben L Antal; Bettina A Dümmler; Claus J Jensen; Maria Deak; Steen Gammeltoft; Ricardo M Biondi
Journal:  EMBO J       Date:  2002-10-15       Impact factor: 11.598

4.  Dephosphorylation of PKCdelta by protein phosphatase 2Ac and its inhibition by nucleotides.

Authors:  Jyoti Srivastava; Jozef Goris; Stephen M Dilworth; Peter J Parker
Journal:  FEBS Lett       Date:  2002-04-10       Impact factor: 4.124

5.  Crystal structure of the catalytic domain of human atypical protein kinase C-iota reveals interaction mode of phosphorylation site in turn motif.

Authors:  Albrecht Messerschmidt; Sofia Macieira; Milko Velarde; Mathias Bädeker; Christian Benda; Anja Jestel; Hans Brandstetter; Torsten Neuefeind; Michael Blaesse
Journal:  J Mol Biol       Date:  2005-09-30       Impact factor: 5.469

6.  Mechanism of activation of protein kinase B by insulin and IGF-1.

Authors:  D R Alessi; M Andjelkovic; B Caudwell; P Cron; N Morrice; P Cohen; B A Hemmings
Journal:  EMBO J       Date:  1996-12-02       Impact factor: 11.598

7.  Essential function of TORC2 in PKC and Akt turn motif phosphorylation, maturation and signalling.

Authors:  Tsuneo Ikenoue; Ken Inoki; Qian Yang; Xiaoming Zhou; Kun-Liang Guan
Journal:  EMBO J       Date:  2008-06-19       Impact factor: 11.598

8.  Irreversible oxidative inactivation of protein kinase C by photosensitive inhibitor calphostin C.

Authors:  R Gopalakrishna; Z H Chen; U Gundimeda
Journal:  FEBS Lett       Date:  1992-12-14       Impact factor: 4.124

9.  PKC alpha protein but not kinase activity is critical for glioma cell proliferation and survival.

Authors:  Angus J Cameron; Katarzyna J Procyk; Michael Leitges; Peter J Parker
Journal:  Int J Cancer       Date:  2008-08-15       Impact factor: 7.396

Review 10.  Emerging roles of pseudokinases.

Authors:  Jérôme Boudeau; Diego Miranda-Saavedra; Geoffrey J Barton; Dario R Alessi
Journal:  Trends Cell Biol       Date:  2006-08-01       Impact factor: 20.808

View more
  62 in total

1.  The Rho target PRK2 regulates apical junction formation in human bronchial epithelial cells.

Authors:  Sean W Wallace; Ana Magalhaes; Alan Hall
Journal:  Mol Cell Biol       Date:  2010-10-25       Impact factor: 4.272

2.  Allosteric modulators can restore function in an amino acid neurotransmitter receptor by slightly altering intra-molecular communication pathways.

Authors:  Ruth Nussinov
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

Review 3.  Fine-tuning multiprotein complexes using small molecules.

Authors:  Andrea D Thompson; Amanda Dugan; Jason E Gestwicki; Anna K Mapp
Journal:  ACS Chem Biol       Date:  2012-07-23       Impact factor: 5.100

4.  Protein kinase C α is a central signaling node and therapeutic target for breast cancer stem cells.

Authors:  Wai Leong Tam; Haihui Lu; Joyce Buikhuisen; Boon Seng Soh; Elgene Lim; Ferenc Reinhardt; Zhenhua Jeremy Wu; Jordan A Krall; Brian Bierie; Wenjun Guo; Xi Chen; Xiaole Shirley Liu; Myles Brown; Bing Lim; Robert A Weinberg
Journal:  Cancer Cell       Date:  2013-09-09       Impact factor: 31.743

5.  Inhibitors paradoxically prime kinases.

Authors:  Stephen V Frye; Gary L Johnson
Journal:  Nat Chem Biol       Date:  2009-07       Impact factor: 15.040

6.  The Role of Regulatory Domains in Maintaining Autoinhibition in the Multidomain Kinase PKCα.

Authors:  Ruth F Sommese; Michael Ritt; Carter J Swanson; Sivaraj Sivaramakrishnan
Journal:  J Biol Chem       Date:  2017-01-03       Impact factor: 5.157

7.  Par6B and atypical PKC regulate mitotic spindle orientation during epithelial morphogenesis.

Authors:  Joanne Durgan; Noriko Kaji; Dan Jin; Alan Hall
Journal:  J Biol Chem       Date:  2011-02-07       Impact factor: 5.157

8.  The art of the chemical probe.

Authors:  Stephen V Frye
Journal:  Nat Chem Biol       Date:  2010-03       Impact factor: 15.040

9.  A chemical genetic approach reveals that p38alpha MAPK activation by diphosphorylation aggravates myocardial infarction and is prevented by the direct binding of SB203580.

Authors:  Sarawut Kumphune; Rekha Bassi; Sebastien Jacquet; Pierre Sicard; James E Clark; Sharwari Verma; Metin Avkiran; Stephen J O'Keefe; Michael S Marber
Journal:  J Biol Chem       Date:  2009-12-07       Impact factor: 5.157

10.  Kinase-dead BRAF and oncogenic RAS cooperate to drive tumor progression through CRAF.

Authors:  Sonja J Heidorn; Carla Milagre; Steven Whittaker; Arnaud Nourry; Ion Niculescu-Duvas; Nathalie Dhomen; Jahan Hussain; Jorge S Reis-Filho; Caroline J Springer; Catrin Pritchard; Richard Marais
Journal:  Cell       Date:  2010-01-22       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.